KRSNAA NSE filing

Krsnaa Diagnostics Schedules Q3FY26 Earnings Conference Call for Feb 6, 2026

The RealCase readLow impact Neutral

Krsnaa Diagnostics Limited will hold its Q3FY26 earnings conference call on February 6, 2026, at 12:30 PM IST. Management will discuss results for the quarter and nine months ended December 31, 2025. Speakers include Rajendra Mutha and Yash Mutha.

Why it matters

This is a standard disclosure of a scheduled conference call for discussing quarterly results. It does not contain any material new information that would significantly impact the company's stock or business operations.

The market read

The announcement is a routine disclosure about a scheduled conference call to discuss financial results. It does not contain any new financial information or forward-looking statements that would indicate a positive or negative sentiment.

Krsnaa Diagnostics Limited has announced its Post Earnings Conference Call, scheduled for Friday, February 06, 2026, at 12:30 PM IST. The call will commence with a management discussion on the results for the quarter and nine months ended December 31, 2025, followed by an interactive Question and Answer session.

PhillipCapital (India) Private Limited is hosting the Q3FY26 Earnings Conference call. The speakers will include Mr. Rajendra Mutha (Chairman & Whole-time Director), Mr. Yash Mutha (Managing Director), Ms. Pallavi Bhatevara (Executive Director), Mr. Mitesh Dave (Group CEO), and Mr. Vivek Jain (Head Investor Relations). The call leader will be Soorya Patra from PhillipCapital India.

The transcript and audio link of the call will be made available on the company's website, www.krsnaadiagnostics.com/investors, subsequent to the event. The company emphasizes adherence to all regulatory guidelines and best governance and transparency practices, including recording the proceedings and sharing participant details.

Filing to action

What to do with a filing like this

Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.

View original filing